These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15801535)

  • 1. [Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].
    Peytavin G
    Med Mal Infect; 2004 Nov; 34 Spec No 2():20-1. PubMed ID: 15801535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Co-infection with HIV and viral hepatitis C].
    Pialoux G
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S218-23. PubMed ID: 17076000
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological interactions in co-infected patients].
    Jáuregui Rueda H; Toibaro J
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S64-7; discussion S74-82. PubMed ID: 16862866
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    McCance-Katz EF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipients.
    Primeggia J; Timpone JG; Kumar PN
    Infect Dis Clin North Am; 2013 Jun; 27(2):473-86. PubMed ID: 23714350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions.
    Kotler DP
    Liver Int; 2009 Mar; 29 Suppl 2():38-46. PubMed ID: 19187071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs?
    Bruno R; Sacchi P; Filice G
    Hepatology; 2002 Feb; 35(2):500-1. PubMed ID: 11826431
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
    Carosi G; Puoti M; Antonucci G; De Luca A; Maserati R; Torti C; Bonfanti P; Bonora S; Bruno R; Gaeta GB; Antinori A; Monforte Ad; Orani A; Sagnelli E; Cargnel A; Cauda R; Mazzotta F; Pastore G; Suter F; Vullo V; ;
    AIDS Rev; 2005; 7(3):161-7. PubMed ID: 16302464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De-"Liver"-ing HIV/hepatitis C virus-coinfected patients from antiretroviral hepatotoxicity.
    Cooper CL
    J Infect Dis; 2007 Sep; 196(5):656-8. PubMed ID: 17674305
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation.
    Antonini M; Ettorre GM; Vennarecci G; D'Offizi G; Narciso P; Del Nonno F; Perracchio L; Visco G; Santoro E
    Hepatogastroenterology; 2004; 51(57):646-8. PubMed ID: 15143883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infections. Hepatitis C virus--some background information.
    TreatmentUpdate; 2008; 20(3):5-8. PubMed ID: 18661654
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.
    Di Perri G; Aguilar Marucco D; Mondo A; Gonzalez de Requena D; Audagnotto S; Gobbi F; Bonora S
    Expert Opin Drug Saf; 2005 Sep; 4(5):821-36. PubMed ID: 16111446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatitis C virus infection in HIV-infected individuals.
    Thomson EC; Main J
    J Viral Hepat; 2008 Nov; 15(11):773-81. PubMed ID: 18435718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
    de Mendoza C; Soriano V
    Antivir Ther; 2005; 10 Suppl 2():M109-15. PubMed ID: 16152712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case study: a 45-year-old gay man with HIV/HCV co-infection.
    JAAPA; 2006 Jan; Suppl():15. PubMed ID: 16429965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.